CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc.

1:09-cv-00184

Overview

Case Number 1:09-cv-00184
Filing Date 2009-03-19
Status Terminated
Termination Date 2012-05-25
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mylan Pharmaceuticals Inc. Operating Company

Represented By

12 Attorneys Listed

Terrence Kearney

UNDELIVERABLE EMAIL 2/12/2019

Ron E. Shulman

Email: ron.shulman@lw.com

Roger J Chin

Email: roger.chin@lw.com

Omar Jabri

Email: ojabri@wsgr.com

Michael D.K. Nguyen

Email: michael.nguyen@arnoldporter.com

Melissa Kopacz

Email: mkopacz@wsgr.com

Matthew A. Argenti

Email: margenti@wsgr.com

Lorelei Westin

Email: lwestin@wsgr.com

Doungamon Fon Muttamara-Walker

District of Columbia Office of

Tel: +1 (240) 447-9752

Administrative Hearings, 441 Fourth Street, N.W.

Dieter H. Hellmoldt

Email: dhellmoldt@wsgr.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Plaintiff

Galderma Laboratories LP NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Galderma Laboratories Inc. Operating Company

Represented By

3 Attorneys Listed

Christine Willgoos

Email: CWillgoos@kramerlevin.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

New York University NPE (University / Research)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Research Foundation of State University of New York NPE (University / Research)

Represented By

3 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Gerald J. Flattmann , Jr.

Email: gflattmann@kslaw.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 5 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (5 found):
U.S. Courts: 5
U.S. District Court 2016-10-27
1:16-cv-01003

Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited

U.S. Family Sibling (["US7211267", "US7749532", "US8206740", "US8394405", "US8394406", "US8470364", "US8709478", "US7232572", "US8603506", "US9241946"])
Status: DED
U.S. District Court 2016-03-31
1:16-cv-00207

Galderma Laboratories L.P. v. Amneal Pharmaceuticals LLC

U.S. Family Sibling (["US7211267", "US7749532", "US8206740", "US8394405", "US8394406", "US8470364", "US8709478", "US7232572", "US8603506", "US9241946"])
Status: DED
U.S. District Court 2011-11-08
1:11-cv-01106

Galderma Laboratories Inc. v. Amneal Pharmaceuticals LLC

U.S. Family Sibling (["US7749532", "US7232572", "US7211267", "US8206740"])
Status: DED
U.S. District Court 2009-09-18
1:09-cv-00703

Research Foundation of State University of New York v. Impax Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2009-07-02
1:09-cv-00483

Research Foundation of State University of New York v. Lupin Limited

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7232572
Methods of treating rosacea
Filed: 2005-02-18
Issued: 2007-06-19
Expired (Term Ended)
Expires: 2025-02-18
US5789395
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
Filed: 1996-08-30
Issued: 1998-08-04
Expired (Term Ended)
Expires: 2016-08-30
US5919775
Method for inhibiting expression of inducible nitric oxide synthase with tetracycline
Filed: 1998-04-16
Issued: 1999-07-06
Expired (Term Ended)
Expires: 2018-04-16
US7211267
Methods of treating acne
Filed: 2002-04-05
Issued: 2007-05-01
Expired (Term Ended)
Expires: 2022-04-05

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

89

Dispositive

54

Granted

12

Denied

1

Pending / Review

56

Motions by Category

Procedural / Extension Motion 17 Motion to Dismiss 5 Motion to Dismiss (FRCP 12(b)(6)) 3 Claim Construction / Markman Filing 18 Motion for Preliminary Injunction / TRO 46

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending
ORDER directing the parties to submit simultaneous opening briefs ofno more than ten (10) pages on September 2,2011, and answering briefs of no more than five (...
Entry #279 • 2011-08-26 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
ORDER directing the parties to submit simultaneous opening briefs ofno more than ten (10) pages on September 2,2011, and answering briefs of no more than five (...
Entry #279 • 2011-08-26 Document →
Motion to Dismiss Denied
ORAL ORDER: IT IS HEREBY ORDERED that Mylan's motion to dismiss exceptional case claims (D.I. 12 ) is DENIED WITHOUT PREJUDICE to renew after judgment on the me...
Entry #252 • 2011-03-24 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
SEALED ANSWERING BRIEF in Opposition re 200 SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87...
Entry #209 • 2010-08-12 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
REDACTED VERSION of 200 SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) by Mylan Pharmaceu...
Entry #204 • 2010-08-04 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
REDACTED VERSION of 201 Declaration of Melissa Kopacz in Support of Mylan's Motion for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary...
Entry #206 • 2010-08-04 Document →

Docket Entries

(492 total)
Pleading / Complaint

COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)

Entry #1 • 2009-03-19
1
Pleading / Complaint

COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)

Entry #1 • 2009-03-19
2
Pleading / Complaint

COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)

Entry #1 • 2009-03-19
2
Pleading / Complaint

COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)

Entry #1 • 2009-03-19
2
Pleading / Complaint

COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)

Entry #1 • 2009-03-19
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc